Press release
Comprehensive Gouty Arthritis Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Gouty Arthritis Market
Gouty Arthritis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The financial scope of the gouty arthritis sector has experienced considerable expansion recently, projecting an increase from a valuation of $3.44 billion in the year 2024 to $3.69 billion by 2025, signifying a compound annual growth rate (CAGR) of 7.3%. This robust expansion observed over the past years stems from several key factors, including the widespread presence of long-term illnesses, greater consumption of alcoholic beverages, a demographic shift toward an older population, the increasing adoption of advanced regenerative treatments, and escalating spending within the healthcare domain.
Gouty Arthritis Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated for the near future is considerable expansion within the gouty arthritis market, projecting a valuation reaching 4.8 billion US dollars by 2029, underpinned by a compound annual growth rate (CAGR) of 6.8%. This forward trajectory in growth is largely fueled by advances in medical infrastructure, rising rates of obesity, a greater prevalence of gout diagnoses, and heightened public consciousness regarding the condition. Key developments set to shape this market sector during the forecast timeframe encompass the escalating need for successful therapeutic interventions, the emergence of regenerative treatments, strides in technology, fresh product introductions, and the attainment of necessary regulatory clearances.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report
What Are the Drivers Transforming the Gouty Arthritis Market?
The escalating incidence of obesity is anticipated to serve as a significant catalyst for the expansion of the gouty arthritis market moving ahead. Obesity, defined as an excessive accumulation of body fat that compromises an individual's well-being and is often quantified via the body mass index (BMI), is on the rise, primarily attributed to greater intake of energy-dense, refined foodstuffs and inactive ways of living. This excess weight promotes gouty arthritis because it elevates uric acid generation while simultaneously impairing the body's mechanism for its elimination, causing uric acid crystals to deposit in the joints. Moreover, the added strain from carrying extra weight intensifies the joint stress, worsening the pain and inflammation characteristic of gout. To illustrate this trend, data released in March 2022 by the World Health Organization, the global health authority within the United Nations structure and based in Switzerland, indicated that roughly one billion people globally-including 650 million adults, 340 million adolescents, and 39 million youngsters-were categorized as obese, a number still climbing. Moreover, forecasts suggest that by the year 2025, roughly 167 million children and adults will contend with associated health issues stemming from being overweight. Consequently, this growing trend in obesity levels directly fuels the progression of the gouty arthritis market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp
What Long-Term Trends Will Define the Future of the Gouty Arthritis Market?
Leading firms within the gouty arthritis sector are intensifying their focus on innovating new therapeutic agents, exemplified by cortrophin gel, aiming to deliver superior and precise treatments for managing this ailment. Cortrophin gel, alternatively termed repository corticotropin injection, represents a refined preparation of adrenocorticotropic hormone (ACTH), and it finds application in addressing a spectrum of inflammatory and autoimmune disorders, gouty arthritis being one such condition. To illustrate, a significant regulatory milestone occurred in October 2023 when ANI Pharmaceuticals, a company based in the United States, secured clearance from the Food and Drug Administration for introducing a new 1-mL vial presentation of Purified Cortrophin Gel, specifically designed as an add-on therapy for select individuals undergoing acute exacerbations of gouty arthritis. Presently, Cortrophin Gel holds the distinction of being the exclusive ACTH therapy endorsed by the FDA for the treatment of suitable candidates suffering from acute gouty arthritis flares.
Which Segments in the Gouty Arthritis Market Offer the Most Profit Potential?
The gouty arthritismarket covered in this report is segmented -
1) By Type: Acute Gouty Arthritis; Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Pain Reliever; Corticosteroids; Xanthine Oxidase Inhibitors; Uricosurics; Others Treatments
3) By Diagnosis: Joint Fluid Test; Blood Test; X-Ray Imaging; Ultrasound; Dual Energy Computed Tomography (CT) Scan; Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Others Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout; Acute Gout Attack (Intermittent Flares); Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits); Chronic Gout With Joint Damage; Chronic Gout With Renal Complications; Chronic Gout With Comorbidities (Hypertension, Diabetes)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp
Which Firms Dominate the Gouty Arthritis Market by Market Share and Revenue in 2025?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the Gouty Arthritis Market?
North America was the largest region in the gouty arthritis market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Gouty Arthritis Market Forecast 2025-2034: Growth Trends and Strategic Shifts here
News-ID: 4276886 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
